HOOKIPA PHARMA INC's ticker is HOOK and the CUSIP is 43906K100. A total of 75 filers reported holding HOOKIPA PHARMA INC in Q1 2022. The put-call ratio across all filers is 1.35 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $15,309 | -59.7% | 18,900 | -33.7% | 0.00% | – |
| Q3 2022 | $38,000 | -17.4% | 28,500 | 0.0% | 0.00% | – |
| Q2 2022 | $46,000 | -30.3% | 28,500 | -1.7% | 0.00% | -100.0% |
| Q1 2022 | $66,000 | -87.4% | 29,000 | -38.3% | 0.00% | -85.7% |
| Q4 2020 | $522,000 | +15.2% | 47,014 | +26.8% | 0.01% | -36.4% |
| Q4 2019 | $453,000 | +64.1% | 37,065 | +0.5% | 0.01% | +37.5% |
| Q3 2019 | $276,000 | – | 36,865 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 530,245 | $3,569,000 | 2.36% |
| Redmile Group, LLC | 1,891,879 | $12,732,000 | 0.36% |
| Artal Group S.A. | 1,134,616 | $7,636,000 | 0.31% |
| DC Investments Management, LLC | 42,857 | $288,000 | 0.16% |
| Hillhouse Capital Management | 657,540 | $4,425,000 | 0.14% |
| HHLR ADVISORS, LTD. | 285,714 | $1,923,000 | 0.04% |
| Baker Brothers Advisors | 892,857 | $6,009,000 | 0.04% |
| Tower Research Capital LLC (TRC) | 6,011 | $40,000 | 0.00% |
| Artisan Partners Limited Partnership | 126,273 | $850,000 | 0.00% |
| SALEM INVESTMENT COUNSELORS INC | 900 | $6,000 | 0.00% |